aTyr Pharma | 8-K: Current report
aTyr Pharma | 8-K: Current report
aTyr Pharma | 8-K: aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update
aTyr Pharma | DEFA14A: Others
aTyr Pharma | DEF 14A: Definitive information statements
aTyr Pharma | 8-K: aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
aTyr Pharma | S-3: Registration statement for specified transactions by certain issuers
aTyr Pharma | 8-K: aTyr Pharma Announces Third Quarter 2023 Results and Provides Corporate Update
aTyr Pharma | 8-K: Current report
aTyr Pharma | 8-K: Current report
aTyr Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
aTyr Pharma | 8-K: aTyr Pharma Announces Second Quarter 2023 Results and Provides Corporate Update
aTyr Pharma | 8-K: Current report
aTyr Pharma | 8-K: aTyr Pharma Announces First Quarter 2023 Results and Provides Corporate Update
aTyr Pharma | DEFA14A: Others
aTyr Pharma | DEFA14A: Others
aTyr Pharma | DEF 14A: Definitive proxy statements
aTyr Pharma | 8-K: Current report
aTyr Pharma | 8-K: aTyr Pharma Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update
aTyr Pharma | PRE 14A: Preliminary proxy statement not related to a contested matter or merger/acquisition
No Data